Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for treating upper respiratory tract infection

An upper respiratory tract and formula technology, used in anti-infective drugs, pharmaceutical formulations, respiratory diseases and other directions, can solve the problems of different drug acceptability, side effects and other problems, and achieve the goal of improving human immune function, improving absorption capacity, and inhibiting the growth of oral bacteria. Effect

Inactive Publication Date: 2018-06-22
江苏娘亲亲母婴健康管理有限公司
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Traditional drugs for the treatment of upper respiratory tract infection are mainly in liquid state, and it is difficult to treat the throat area. The treatment effect is different, and different groups of people have different acceptance of drugs. If the dosage is not well controlled, it will cause side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Weigh each raw material according to the following proportions: honeysuckle 35, bird's nest 30, mint powder 20, fructooligosaccharide 4, perilla leaf 8, Nepeta 8, Fangfeng 6, add to the mixer in turn, the mixing temperature is 100°C, and the rotating speed is 300°C. rpm, the mixing time is 1.5 hours, the screw speed is 200 rpm, the feeder speed is 120 rpm; the temperature of each section of the extruder is 100°C, and it is made into a pill shape.

[0031] In this embodiment, by setting the ratio of honeysuckle and bird's nest in the formula drug to a high proportion, the drug properties of the main drug can be improved, and the mixing temperature and mixing speed can be controlled at the maximum, so that the degree of fusion of the drug can be improved, so that the prepared The drug properties of the drug are relatively strong, and are suitable for people with serious conditions.

Embodiment 2

[0033] Weigh each raw material according to the following proportions: honeysuckle 28, bird's nest 23, mint powder 30, fructooligosaccharide 6, perilla leaf 9, nepeta 10, windproof 6, add to the mixer in turn, the mixing temperature is 80 ℃, and the rotating speed is 100 rpm, the mixing time is 1.5 hours, the screw speed is 150 / min, the feeder speed is 100 rpm; the temperature of each section of the extruder is 90°C, and it is made into a pill shape.

[0034] In this example, by setting the bottom ratio of honeysuckle and bird’s nest in the formula drug, and using a high ratio of mint powder, the strong drug properties of the drug can be reduced, and the mixing temperature and mixing speed are controlled at low values, and the stirring is prolonged. The heating time can soften the properties of the medicine, so that the prepared medicine has milder properties and is suitable for people with severe and weak diseases.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition for treating upper respiratory tract infection. The composition for treating upper respiratory tract infection comprises 25-35 parts of honeysuckle flowers, 20-30parts of cubilose, 20-30 parts of mint powder, 4-8 parts of fructo-oligosaccharide, 8-10 parts of folium perillae, 8-12 parts of fineleaf schizonepeta herb and 6-8 parts of radix saposhnikoviae. Thecomposition is beneficial to proliferation of bifidobacteria and other beneficial bacteria, the pH value in the intestines is lowered through organic acid generated during metabolism, synthesis of vitamins is improved, and the immune function of the human body is improved; then the medicine property of medicine can be accelerated in cooperation with folium perillae, fineleaf schizonepeta herb andradix saposhnikoviae, the medical effect is improved, the composition medicine is prepared to be in a pill shape, a patient can contain pills in the mouth for natural melting, the absorption capacityof the upper respiratory tract is improved, and accordingly the medical effect of the medicine is improved.

Description

technical field [0001] The invention relates to the field of formulas for treating upper respiratory tract infections, in particular to a formula for treating upper respiratory tract infections. Background technique [0002] Respiratory tract infection is divided into upper respiratory tract infection and lower respiratory tract infection. Upper respiratory tract infection refers to the general term of acute inflammation from the nasal cavity to the throat, and is the most common infectious disease. Lower respiratory tract infection is the most common infectious disease. During treatment, the pathogen causing infection must be identified to select effective antibiotics. About 90% of upper respiratory tract infections are caused by viruses, and bacterial infections are often secondary to viral infections. The disease can come on in all seasons and at any age, and it can be transmitted by droplets containing virus, droplets, or contaminated utensils. Often when the body's re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/538A61P11/00A61P31/00A61K35/57A61K31/702
CPCA61K31/702A61K35/57A61K36/238A61K36/355A61K36/534A61K36/535A61K36/538A61K2300/00
Inventor 孔祥雷郭晓蔷
Owner 江苏娘亲亲母婴健康管理有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products